What You Need to Know

• More than 3,000 lawsuits are coordinated in multidistrict litigation over the devices, which are implanted under the skin to provide repeated intravenous chemotherapy or other medications.
• Lawsuits allege that the devices are defective, often causing blood infections, thrombosis or fractures.
• The plaintiff, Robert Cook, who alleged he developed an infection from a Bard PowerPort M.R.I Implantable Port in 2022 at the Mayo Clinic in Rochester, Minnesota.

A Subscription is Required to Access this Content.
Subscribe to Law.com today for:

• Exclusive Reporting - Fast, authoritative coverage and sharp analysis.
• Integrated Insights - Compass and Radar context built right into articles.
• Personalized Experience - Tailored homepage content and curated newsletters.
• Smart Search & Alerts - Powerful search and real‑time updates.

Already a Subscriber? Log In.

Questions? Contact an Account Specialist at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)

Continue Reading

This week: The U.S. Supreme Court heard arguments on Monsanto’s defense of federal preemption in lawsuits over its Roundup pesticide. The first bellwether trial among more than 3,000 lawsuits over Bard’s PowerPort medical devices began in Arizona. Find out who stepped in to represent fertilizer manufacturers, such as Koch Industries and The Mosaic Co., in a string of new antitrust lawsuits.

Two co-lead plaintiffs’ counsel in the Roundup multidistrict...

Read Full Story: http://www.law.com/2026/04/29/first-bellwether-trial-opens-against-bard-over-...